Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News

  News Archive

Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
Tuesday, July 28, 2015
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.

Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Monday, July 27, 2015
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.

Funding Boost for Diabetes Research
Friday, July 24, 2015
Programme of research could be a game-changer for people with Type 1 diabetes and insulin-dependent Type 2 diabetes.

New Material Forges the Way for 'Stem Cell Factories'
Thursday, July 23, 2015
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.

Liver Regrown from Stem Cells
Wednesday, July 22, 2015
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.

Immunotherapy Shows Promise for Myeloma
Wednesday, July 22, 2015
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.

PacBio, Singapore's GIS Expand Collaboration on Infectious Disease
Wednesday, July 22, 2015
Together, GIS and PacBio will combine efforts to advance research in infectious diseases, genomics, sequence analysis, and translational healthcare in Singapore.

'Google Maps' for the Body
Wednesday, July 22, 2015
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.

Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
Tuesday, July 21, 2015
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 2367
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!